期刊文献+

新生儿早期母乳性黄疸微生态治疗效果分析 被引量:6

下载PDF
导出
摘要 目的探讨新生儿早期高胆红素血症的微生态治疗效果。方法对该院儿科2010年10月至2012年10月治愈出院的40例新生儿早期高胆红素血症患儿病历资料进行回顾性分析,40例患儿随机分为两组:治疗组20例予以光疗加微生态疗法(口服益生菌)、充分喂养;对照组20例予以常规治疗(光疗为主)。结果两组患儿均治愈出院,无1例并发症。平均黄疸消退时间:治疗组(3.50±1.24)d,对照组(5.50±1.34)d,P<0.01;平均住院时间:治疗组(4.50±1.43)d,对照组(7.20±1.45)d,P<0.01。两组疗效比较差异有统计学意义。结论微生态疗法(口服益生菌)、充分喂养能有效促进新生儿早期高胆红素血症患儿黄疸消退。
出处 《重庆医学》 CAS CSCD 北大核心 2013年第17期2016-2018,共3页 Chongqing medicine
  • 相关文献

参考文献9

  • 1洪庆成,王薇.实用儿科新诊疗[M].上海:上海交通大学出版社, 2011: 289 -291.
  • 2邵肖梅,叶鸿瑁,丘小汕.实用新生儿学[M].北京:人民卫生出版社,2011.347.
  • 3Martin RJ.Fanaroff AA,Walsh MC.Fanaroff and martinsneonantal-pathophyiology medicine-disease of the fetusand infant 8th ed[J].Philadelphia; Elsevier Mosby,2006,24(12):1431-1434.
  • 4李薇,陈自励.新生儿黄疸治疗中的矛盾和对策[J].实用儿科临床杂志,2012,27(14):1064-1066. 被引量:20
  • 5Lp S,Chung M,Kulig J,et al.Amerrican academy of ped-iatrics s sub-committee on hyperbilirubinemia,an evidencebased rexiew of important issues concerning neonatal hy-perbilirubinemia[J].Pediatrics,2004,114(1):130-132.
  • 6邵晓梅,桂永浩.胎儿和新生儿脑损伤[M].上海:上海科技出版社,2008:358-362.
  • 7Huzebos CV,Bos AF,Anttila E,et al.Early corticosteroidtreatment does not affect severity of onconjugate Hyper-bilirubinemia inextremelow birth weight preterm infants[J].Acta Paediar,20ll,100(2):170-174.
  • 8Golombek SG,Navarro M,Negro S,et al.Administrationof intravenous immunoglobulin is not free of risk in theneonatal period[J].Arch Pediatr,20l0,17(3):298-301.
  • 9邓焕明.蒙脱石散治疗病理性新生儿黄疸的临床观察[J].中国当代医药,2011,18(6):49-49. 被引量:12

二级参考文献21

  • 1American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirnbinemia in the newborn infant 35 or more weeks of gestation [ J ]. Pediatrics,2004,114 ( 1 ) :297 - 316.
  • 2Maisels MJ, Bhutani VK, Bogen D, et al. Hyperbilirnbinemia in the new- born infant I> 35 weeks gestation:An update with clarifications J 1. Pe- diatrics,2009,124 (4) : 1193 - 1198.
  • 3Hulzebos CV, Bos AF, Anttila E, et al. Early corticosteroid treatment does not affect severity of uneonjugated hyperbilirubinemia in extreme low birth weight preterm infants [ J]. Acta Paediatr, 2011,100 ( 2 ) : 170 - 174.
  • 4Cupen'us FJ, Hafkamp AM, Hu|zebos CV, et al. Pharmacological thera- pies for unconjugated hyperbilirubinemia [ J ]. Curr Pharm Des,2009,15 (25) :2927 - 2935.
  • 5Eghbalian F, Pourhossein A, Zandevakili I-I, et al. Effect of clofibrate in non- hemolytic indirect hyperbilirubinemia in full term neonates [ J ]. Indian J Pediatr,2007,74 ( 11 ) : 1003 - 1006.
  • 6Taeusch HW, Ballard RA. Avery's diseases of the newborn[ M ]. 7th ed. Beijing : Science Press ,Harcourt Asia, W. B. Saunders ,2001 : 1041.
  • 7Stevenson DK, Wong RJ. Metalloporphyrins in the mangement of neo- natal hyperbilirubinemia[ J ]. Semin Fetal Neonatal Med,2010,15 ( 3 ) : 164 - 168.
  • 8Golombek SG, Navarro M, Negre S, et al. Administration of intravenous immunoglobulin is not free of risk in the neonatal period[ J]. Arch Pe- diatr,2010,17 ( 3 ) :298.
  • 9Lp S, Chung M, Kulig J, et al. American Academy of Pediatrics Sub- Committee on Hyperbilirubinemia. An evidence based review of impor- tant issues concerning neonatal hyperbilirubinemia [ J ]. Pediatrics, 2004,114( 1 ) :el30.
  • 10Johnson L, Bhutani VK, Karp K,et al. Clinical report from the pilot USA Kernicterous Registry ( 1992 - 2004 ) [ J ]. J Perinatol, 2009,29 ( suppl 1 ) :25 -45.

共引文献196

同被引文献44

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部